Cluster-Randomized Trial of a Mobile Phone Personalized Behavioral Intervention for Blood Glucose Control
Open accessThe DOI matches its Crossref record; 26 of the 28 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To test whether adding mobile application coaching and patient/provider web portals to community primary care compared with standard diabetes management would reduce glycated hemoglobin levels in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: A cluster-randomized clinical trial, the Mobile Diabetes Intervention Study, randomly assigned 26 primary care practices to one of three stepped treatment groups or a control group (usual care). A total of 163 patients were enrolled and included in analysis. The primary outcome was change in glycated hemoglobin levels over a 1-year treatment period. Secondary outcomes were changes in patient-reported diabetes symptoms, diabetes distress, depression, and other clinical (blood pressure) and laboratory (lipid) values. Maximal treatment was a mobile- and web-based self-management patient coaching system and provider decision support. Patients received automated, real-time educational and behavioral messaging in response to individually analyzed blood glucose values, diabetes medications, and lifestyle behaviors communicated by mobile phone. Providers received quarterly reports summarizing patient’s glycemic control, diabetes medication management, lifestyle behaviors, and evidence-based treatment options. RESULTS: The mean declines in glycated hemoglobin were 1.9% in the maximal treatment group and 0.7% in the usual care group, a difference of 1.2% (P = 0.001) over 12 months. Appreciable differences were not observed between groups for patient-reported diabetes distress, depression, diabetes symptoms, or blood pressure and lipid levels (all P > 0.05). CONCLUSIONS: The combination of behavioral mobile coaching with blood glucose data, lifestyle behaviors, and patient self-management data individually analyzed and presented with evidence-based guidelines to providers substantially reduced glycated hemoglobin levels over 1 year.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Eleven of the studies reported a decrease of HbA1c within the app intervention groups, yielding a mean difference of –0.42% [50-52,54-61], but only 1 study reported a significant change of –1.1% (P<.001) [56].”
From Effectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review (2021) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cholesterol levels were reported in 7 studies (407 patients in the intervention groups and 348 patients in the control groups).”
From Effectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review (2021) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“12 were focused on T2DM (743 patients in the intervention groups and 645 patients in the control groups) [50-61]”
From Effectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review (2021) · cites this paper as [58]
The cited source says what the claim attributes to it.
In the citing paper
“None of the 7 studies that reported on blood pressure found significant differences either within or between groups [51-53,55,57,58,61].”
From Effectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review (2021) · cites this paper as [58]
The cited source says what the claim attributes to it.
In the citing paper
“High-density lipoprotein (HDL) cholesterol and low-density lipoprotein (LDL) cholesterol were both included in 7 studies [52,53,55-58,61].”
From Effectiveness of Disease-Specific mHealth Apps in Patients With Diabetes Mellitus: Scoping Review (2021) · cites this paper as [58]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Systems for routine surveillance for people with diabetes mellitus
Griffin, S., & Kinmonth, A. L. (1998) · doi:10.1002/14651858.cd000541 · Cited by 87
RetractedThe PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Analysis of Semiparametric Regression Models for Repeated Outcomes in the Presence of Missing Data
Robins, J. M., Rotnitzky, A., & Zhao, L. P. (1995) · Journal of the American Statistical Association · doi:10.1080/01621459.1995.10476493 · Cited by 1,595
Assessing Psychosocial Distress in Diabetes
Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., & Jackson, R. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.626 · Cited by 1,575
Standards of Medical Care in Diabetes—2008
Dora, J. M., Kramer, C. K., & Canani, L. H. (2008) · Diabetes Care · doi:10.2337/dc08-0109 · Cited by 1,409
Standards of Medical Care in Diabetes—2008
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-s012 · Cited by 1,377
Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006
Cowie, C. C., Rust, K. F., Ford, E. S., Eberhardt, M. S., Byrd-Holt, D. D., Li, C., Williams, D. E., Gregg, E. W., Bainbridge, K. E., Saydah, S. H., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1296 · Cited by 1,154 · cited 1×
“Costs exceed $100 billion annually (1,2).”
Peyrot, M., Rubin, R. R., Lauritzen, T., Snoek, F. J., Matthews, D. R., & Skovlund, S. E. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01644.x · Cited by 931 · cited 1×
“Only 55% of individuals with type 2 diabetes receive diabetes education (10); 16% report adhering to recommended self-management activities (11).”
BackgroundSimple sample size calculation for cluster-randomized trials
Hayes, R. J., & Bennett, S. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.2.319 · Cited by 822
Improvements in Diabetes Processes of Care and Intermediate Outcomes: United States, 1988–2002
Saaddine, J. B., Cadwell, B., Gregg, E. W., Engelgau, M. M., Vinicor, F., Imperatore, G., & Narayan, K. M. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-7-200604040-00005 · Cited by 571
Renders, C. M., Valk, G. D., Griffin, S. J., Wagner, E., van Eijk, J. T., & Assendelft, W. J. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001481 · Cited by 494 · cited 1×
“Only 55% of individuals with type 2 diabetes receive diabetes education (10); 16% report adhering to recommended self-management activities (11).”
BackgroundDevelopment of a brief diabetes distress screening instrument
Fisher, L., Glasgow, R. E., Mullan, J. T., Skaff, M. M., & Polonsky, W. H. (2008) · The Annals of Family Medicine · doi:10.1370/afm.842 · Cited by 474 · cited 2×
“We used the 9-item version of the Self-Completion Patient Outcome Instrument to assess patientreported symptomsassociatedwithdiabetes (16,17) and the 17-item Diabetes Distress Scale (18,19).”
MethodProjecting the Future Diabetes Population Size and Related Costs for the U.S.
Huang, E. S., Basu, A., O'Grady, M., & Capretta, J. C. (2009) · Diabetes Care · doi:10.2337/dc09-0459 · Cited by 414 · cited 1×
“Costs exceed $100 billion annually (1,2).”
Quinn, C. C., Clough, S. S., Minor, J. M., Lender, D., Okafor, M. C., & Gruber-Baldini, A. (2008) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0283 · Cited by 406 · cited 1×
“The widespread distribution of mobile phones and electronic communication, across socioeconomic, sex, and age-groups, combined with the ability to process and communicate data in real time, make these modalities ideal platforms to create simple, effective, diabetes management programs (14).”
BackgroundSelf-citationIndividual patient education for people with type 2 diabetes mellitus
Duke, S.-A. S., Colagiuri, S., & Colagiuri, R. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005268.pub2 · Cited by 361 · cited 1×
“Our finding is consistent with the Cochrane Collaboration review, suggesting the benefit of individual education on glycemic control (24).”
ResultShea, S., Weinstock, R. S., Starren, J., Teresi, J., Palmas, W., Field, L., Morin, P., Goland, R., Izquierdo, R. E., Wolff, L. T., et al. (2006) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m1917 · Cited by 312 · cited 1×
“10, similar to a previously reported study (20,21).”
ResultQuinn, C. C., Gruber‐Baldini, A. L., Shardell, M. D., Weed, K., Clough, S. S., Peeples, M., Terrin, M. L., Bronich-Hall, L., Barr, E. A., & Lender, D. (2009) · Contemporary Clinical Trials · doi:10.1016/j.cct.2009.02.004 · Cited by 78 · cited 5×
“Although low glycated hemoglobin does not imply that diabetes is being well managed, well managed diabetes is characterized by glycated hemoglobin at normal or near-normal levels (13).”
BackgroundInfluentialSelf-citationReducing Cardiovascular Risk in Type 2 Diabetes
Solomon, C. G. (2003) · New England Journal of Medicine · doi:10.1056/nejme020172 · Cited by 58
Gæde, P., Jepsen, P. V., Larsen, J. N. B., Jensen, G. V. H., Parving, H., & Pedersen, O. B. (2003) · PubMed · Cited by 49
A new self-completion outcome measure for diabetes: is it responsive to change?
Whitty, P., Steen, N., Eccles, M., McColl, E., Hewison, J., Meadows, K., Clapp, Z., & Hutchinson, A. (1997) · Quality of Life Research · doi:10.1023/a:1018443628933 · Cited by 43 · cited 1×
“We used the nineitem version of the Self-Completion Patient Outcome Instrument to assess patient-reported symptoms associated with diabetes (16,17) and the 17-itemDiabetes Distress Scale (18,19).”
MethodDeveloping outcome measures for ambulatory care—An application to asthma and diabetes
McColl, E., Steen, I. N., Meadows, K., Hutchinson, A., Eccles, M. P., Hewison, J., Fowler, P., & Blades, S. (1995) · Social Science & Medicine · doi:10.1016/0277-9536(95)00120-v · Cited by 39 · cited 1×
“We used the nineitem version of the Self-Completion Patient Outcome Instrument to assess patient-reported symptoms associated with diabetes (16,17) and the 17-itemDiabetes Distress Scale (18,19).”
MethodEnlisting the Help of the Largest Health Care Workforce—Patients
Cleland, J. G. F., & Ekman, I. (2010) · JAMA · doi:10.1001/jama.2010.1387 · Cited by 38
Verbeke, G. N., & Lesaffre, E. M. E. H. (2006) · Wiley Encyclopedia of Clinical Trials · doi:10.1002/9780471462422.eoct029 · Cited by 1
Cited by
Free, C., Phillips, G., Galli, L., Watson, L., Felix, L., Edwards, P., Patel, V., & Haines, A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001362 · Cited by 1,766
“Four trials of a diabetes care intervention, three involving text messages and the other involving video messages, reported statistically significant decreases in HBA1C, which were of borderline clinical significance [69–73].”
Hamine, S., Gerth-Guyette, E., Faulx, D., Green, B. B., & Ginsburg, A. S. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.3951 · Cited by 1,149
“One study demonstrated the dual benefits of both better access to patient data and mobile coaching [65].”
Mobile phone-based interventions for smoking cessation
Whittaker, R., McRobbie, H., Bullen, C., Rodgers, A., & Gu, Y. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006611.pub4 · Cited by 1,079
Mobile Health Technology Evaluation
Kumar, S., Nilsen, W. J., Abernethy, A., Atienza, A., Patrick, K., Pavel, M., Riley, W. T., Shar, A., Spring, B., Spruijt-Metz, D., et al. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.03.017 · Cited by 900
Self-citationWhitehead, L., & Seaton, P. (2016) · Journal of Medical Internet Research · doi:10.2196/jmir.4883 · Cited by 743
“Only 1 study [23] specifically sought to explore whether sending clinicians’ data improved clinical outcomes.”
BackgroundInfluential
Metadata
- Authors
- Quinn, C. C., Shardell, M. D., Terrin, M. L., Barr, E. A., Ballew, S. H., & Gruber-Baldini, A. L.
- Affiliations
- University of Maryland, Baltimore (US)
- Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland
- Corresponding author
- Quinn, Charlene C.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-08-19
- Volume
- 34
- Issue
- 9
- Pages
- 1934-1942
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3161305
- OpenAlex
- W2157806282
- Cited by
- 650
- References
- 28
- Citations by year
- 2026: 12 · 2025: 22 · 2024: 34 · 2023: 38 · 2022: 39 · 2021: 72 · 2020: 50 · 2019: 57 · 2018: 66 · 2017: 66 · 2016: 65 · 2015: 38 · 2014: 35 · 2013: 35 · 2012: 18
- FWCI
- 53.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Maryland Industrial Partnerships
- A. James Clark School of Engineering
- Maryland Technology Enterprise Institute
- National Institute on Aging (P30AG028747)
- Topics
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, HbA1c, mobile phone intervention, diabetes self-management, web portal, primary care, blood glucose monitoring, diabetes distress, depression, stepped care
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Life Style, Male, Middle Aged, Patient Education as Topic, Self Care, Cell Phone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

